SEARCH

SEARCH BY CITATION

References

  • 1
    Matsumoto T, Tanibuchi Y, Takano A, Kobayashi O, Wada K. A nationwide survey of drug-related psychiatric illness in hospitals with psychiatric inpatient units. The Research Report of 2012 Health Labour Sciences Research Grant (Research on Regulatory Science of Pharmaceuticals and Medical Devices) from the Ministry of Health, Labour and Welfare of Japan, pp. 111144, 2013 (in Japanese).
  • 2
    Stogner JM, Miller BL. Investigating the ‘bath salt’ panic: The rarity of synthetic cathinone use among students in the United States. Drug Alcohol Rev. 2013; 32: 545549.
  • 3
    Forrester MB, Kleinschmidt K, Schwarz E, Young A. Synthetic cannabinoid and marijuana exposures reported to poison centers. Hum. Exp. Toxicol. 2012; 31: 10061011.
  • 4
    Hoyte CO, Jacob J, Monte AA, Al-Jumaan M, Bronstein AC, Heard KJ. A characterization of synthetic cannabinoid exposures reported to the National Poison Data System in 2010. Ann. Emerg. Med. 2012; 60: 435438.
  • 5
    McGuinness TM, Newell D. Risky recreation: Synthetic cannabinoids have dangerous effects. J. Psychosoc. Nurs. Ment. Health Serv. 2012; 50: 1618.
  • 6
    Kasick DP, McKnight CA, Klisovic E. ‘Bath salt’ ingestion leading to severe intoxication delirium: Two cases and a brief review of the emergence of mephedrone use. Am. J. Drug Alcohol Abuse 2012; 38: 176180.
  • 7
    Slomski A. A trip on ‘bath salts’ is cheaper than meth or cocaine but much more dangerous. JAMA 2012; 308: 24452447.
  • 8
    Kuroki Y, Iida K, Takeuchi A et al. A research on the acute intoxication cases by the ‘Gouhou Herb,’ of which information were reported to the Japan Poison Information Center. Jpn. J. Clin. Toxicol. 2011; 24: 323327 (in Japanese).
  • 9
    Wada K, Funada M, Tomiyama K, Aoo N. Current situation of abuse of designer drugs including the ‘Dappou Herb’ in Japan. Nippon Yakuzaishi-kai Zasshi 2013; 65: 1317 (in Japanese).
  • 10
    Matsumoto T, Okada T. Designer drugs as a cause of homicide. Addiction 2006; 101: 16661667.
  • 11
    Miyajima M, Matsumoto T, Ito S. 2C-T-4 intoxication: Acute psychosis caused by a designer drug. Psychiatry Clin. Neurosci. 2008; 62: 243.
  • 12
    Tanibuchi Y, Matsumoto T, Kobayashi O, Wada K. Clinical characteristics of ‘dappou herb’ use-disorder patients at the drug dependence clinic: A comparison with methamphetamine use-disorder patients. Seishin Shinkeigaku Zasshi (Psychiatria et Neurologia Japonica) 2013; 115: 463476 (in Japanese).
  • 13
    Matsumoto T, Ozaki S, Kobayashi O, Wada K. Current situation and clinical characteristics of sedative-related disorder patients in Japan: A comparison with methamphetamine-related disorder patients. Seishin Shinkeigaku Zasshi (Psychiatria et Neurologia Japonica) 2011; 113: 11841198 (in Japanese).
  • 14
    Matsumoto T, Kamijo A, Miyakawa T et al. Methamphetamine in Japan: The consequences of methamphetamine abuse as a function of route of administration. Addiction 2002; 97: 809817.
  • 15
    Khantzian EK. Self-regulation and self-medication factors in alcoholism and the addictions: Similarities and differences. In: Galanter M (ed.). Recent Developments in Alcoholism. Plenum, New York, 1990; 251277.